Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Alveus Therapeutics ApS
APS
Active
CVR 44689790
Palægade 4, 1261
København K
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2024 · 2 years old
9 employees
Monitor
Share
Denmark
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Alveus Therapeutics ApS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Gross profit
DKK millions
0M
6M
13M
19M
25M
-1M
2024
22M
2025
EBITDA
DKK millions
4M
1M
-2M
-5M
-8M
-6M
2024
3M
+150%
2025
Income statement
DKK thousands
Item
2024
2025
Gross profit
-969
22.057
Staff expenses
-4.640
-19.337
EBITDA
-5.608
2.720
Depreciation & amort.
-0
-0
EBIT
-5.608
2.720
Net financials
-0
-623
Profit before tax
-5.608
2.097
Tax
-0
-0
Net profit
-5.608
2.097
Balance sheet
DKK thousands
Item
2024
2025
Total assets
480
65.129
Equity
-5.568
59.681
Long-term debt
0
0
Short-term debt
6.048
5.448
Total debt
6.048
5.448
Financial ratios
5-year trend
EBITDA margin (of gross profit)
12.3%
This company
2024
2025
Equity ratio
91.6%
This company
38.2%
Market median
+140% vs market
2024
2025
Return on equity
3.5%
This company
18.4%
Market median
-81% vs market
2024
2025
Net profit margin (of gross profit)
9.5%
This company
2024
2025
Asset turnover (of gross profit)
0.34×
This company
2024
2025
Debt / equity
0.09×
This company
0.62×
Market median
+85% vs market
2024
2025
Annual reports & filings
Annual report 2025
Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via CVR / Virk · Period 2024-03-05 – 2024-12-31
View
PDF
More on Alveus Therapeutics ApS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
